» Articles » PMID: 29184003

IL-10 Promoter Transactivation by the Viral K-RTA Protein Involves the Host-cell Transcription Factors, Specificity Proteins 1 and 3

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 Nov 30
PMID 29184003
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) causes a persistent infection, presenting latent and lytic replication phases during its life cycle. KSHV-related diseases are associated with deregulated expression of inflammatory cytokines, including IL-6 and IL-10, but the mechanisms underlying this dysregulation are unclear. Herein, we report a molecular mechanism for KSHV-induced gene expression. KSHV replication and transcription activator (K-RTA) is a molecular switch for the initiation of expression of viral lytic genes, and we describe, for the first time, that K-RTA significantly activates the promoter of the human gene. Of note, mutations involving a basic region of K-RTA reduced the association of K-RTA with the promoter. Moreover, the host-cell transcription factors, specificity proteins (SP) 1 and 3, play a pivotal cooperative role in K-RTA-mediated transactivation of the promoter. K-RTA can interact with SP1 and SP3 directly , and electrophoresis mobility shift assays (EMSAs) revealed co-operative interaction involving K-RTA, SP1, and SP3 in binding to the promoter. As DNase I footprinting assays indicated that K-RTA did not affect SP3 binding to the promoter, SP3 can function to recruit K-RTA to the promoter. These findings indicate that K-RTA can directly contribute to up-regulation via a functional interplay with the cellular transcription factors SP1 and SP3.

Citing Articles

Induced dual-target rebalance simultaneously enhances efficient therapeutical efficacy in tumors.

Zhang X, Ding T, Yang F, Xu H, Zhang J, Bai Y Cell Death Discov. 2024; 10(1):249.

PMID: 38782895 PMC: 11116470. DOI: 10.1038/s41420-024-02018-y.


Analysis of Chromatin Accessibility Changes Induced by BMMC Recognition of Foot-and-Mouth Disease Virus-like Particles through ATAC-seq.

Han W, Zhang J, Li M, An M, Li L Int J Mol Sci. 2023; 24(23).

PMID: 38069369 PMC: 10706935. DOI: 10.3390/ijms242317044.


Kaposi's sarcoma-associated herpesvirus replication and transcription activator protein activates CD274/PD-L1 gene promoter.

Miyazawa M, Yamamoto Y, Katayama K, Sugimoto Y, Noguchi K Cancer Sci. 2022; 114(4):1718-1728.

PMID: 36411531 PMC: 10067386. DOI: 10.1111/cas.15673.


Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Alomari N, Totonchy J Viruses. 2020; 12(10).

PMID: 32998419 PMC: 7600567. DOI: 10.3390/v12101097.


Human Virus Transcriptional Regulators.

Liu X, Hong T, Parameswaran S, Ernst K, Marazzi I, Weirauch M Cell. 2020; 182(1):24-37.

PMID: 32649876 PMC: 7346790. DOI: 10.1016/j.cell.2020.06.023.


References
1.
Boshoff C, Chang Y . Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med. 2001; 52:453-70. DOI: 10.1146/annurev.med.52.1.453. View

2.
Spencer J, Lockridge K, Barry P, Lin G, Tsang M, Penfold M . Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol. 2002; 76(3):1285-92. PMC: 135865. DOI: 10.1128/jvi.76.3.1285-1292.2002. View

3.
Murray P . Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol. 2006; 6(4):379-86. DOI: 10.1016/j.coph.2006.01.010. View

4.
Asou H, Said J, Yang R, Munker R, Park D, Kamada N . Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood. 1998; 91(7):2475-81. View

5.
Chang P, Miller G . Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein. J Virol. 2004; 78(19):10657-73. PMC: 516418. DOI: 10.1128/JVI.78.19.10657-10673.2004. View